Is there a role for sentinel node biopsy in the pre-operative ultrasound positive axilla? M. AhmedF. JozsaM. Douek Editorial 08 June 2017 Pages: 225 - 228
Predictors of distress in female breast cancer survivors: a systematic review Ania SyrowatkaAude MotulskyRobyn Tamblyn Review Open access 28 May 2017 Pages: 229 - 245
Breast cancer oral anti-cancer medication adherence: a systematic review of psychosocial motivators and barriers Cheryl LinRachel ClarkLeah L. Zullig Review 01 June 2017 Pages: 247 - 260
Breast cancer electron intraoperative radiotherapy: assessment of preoperative selection factors from a retrospective analysis of 758 patients and review of literature S. TakanenA. GambirasioL. F. Cazzaniga Review 03 June 2017 Pages: 261 - 271
Meta-analysis of pre-operative magnetic resonance imaging (MRI) and surgical treatment for breast cancer Nehmat HoussamiRobin M. TurnerMonica Morrow Review 06 June 2017 Pages: 273 - 283
Reassessing risk models for atypical hyperplasia: age may not matter Emanuele MazzolaSuzanne B. CoopeyKevin S. Hughes Review 06 June 2017 Pages: 285 - 291
Subtype-specific prognostic impact of different immune signatures in node-negative breast cancer A.-S. HeimesK. MadjarM. Schmidt Preclinical study 05 June 2017 Pages: 293 - 300
The financial impact and drivers of hospital charges in contralateral prophylactic mastectomy and reconstruction: a Nationwide Inpatient Sample hospital analysis Alexandra BucknorAnmol ChatthaSamuel J. Lin Preclinical study 20 June 2017 Pages: 301 - 310
Survival improvement in hormone-responsive young breast cancer patients with endocrine therapy Tae In YoonUi-Kang HwangHee Jeong Kim Clinical trial 10 June 2017 Pages: 311 - 320
The efficacy of lymphaticovenular anastomosis in breast cancer-related lymphedema H. WintersH. J. P. TielemansD. J. O. Ulrich Clinical trial Open access 12 June 2017 Pages: 321 - 327
Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial Javier CortésHope S. RugoJoyce O’Shaughnessy Clinical trial Open access 13 June 2017 Pages: 329 - 341
IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients Carlo PalmieriRob C. SteinOn behalf of the IRIS trial participants Clinical trial Open access 13 June 2017 Pages: 343 - 353
Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer Rodrigo GoncalvesKatherine DeSchryverMatthew J. Ellis Clinical trial Open access 13 June 2017 Pages: 355 - 364
Antitumor activity and safety profile of weekly carboplatin plus paclitaxel in metastatic breast cancer: a ten-year, monocentric, retrospective study Claudio VernieriMonica MilanoFilippo de Braud Clinical trial 14 June 2017 Pages: 365 - 373
A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1104) Lori J. GoldsteinFengmin ZhaoGeorge W. Sledge Clinical trial 16 June 2017 Pages: 375 - 382
COX2 induction: a mechanism of endocrine breast cancer resistance? Brandi L. ClarkMichael A. MurphyLandry K. Kamdem Clinical Trial 21 June 2017 Pages: 383 - 389
The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients Victoria SopikPing SunSteven A. Narod Epidemiology 10 June 2017 Pages: 391 - 402
Incidence and treatments of DCIS in octogenarians: grade matters Erin P. WardAnna WeissSarah L. Blair Epidemiology 12 June 2017 Pages: 403 - 409
Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review Marina De BrotStarr Koslow MautnerTari A. King Epidemiology 13 June 2017 Pages: 411 - 420
Interaction of mammographic breast density with menopausal status and postmenopausal hormone use in relation to the risk of aggressive breast cancer subtypes Lusine YaghjyanRulla M. TamimiCeline M. Vachon Epidemiology 17 June 2017 Pages: 421 - 431
Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment Alexander LiedeCarol A. MansfieldD. Gareth Evans Epidemiology Open access 17 June 2017 Pages: 433 - 444
Utilization of hypofractionated whole-breast radiation therapy in patients receiving chemotherapy: a National Cancer Database analysis Tejan P. DiwanjiJason K. MolitorisSteven J. Feigenberg Epidemiology 21 June 2017 Pages: 445 - 453
Opioid use among female breast cancer patients using different adjuvant endocrine therapy regimens Xi TanTareq Fabian CamachoRajesh Balkrishnan Epidemiology 21 June 2017 Pages: 455 - 465
Antibody-based therapies for the treatment of brain metastases from HER2-positive breast cancer: time to rethink the importance of the BBB? Vasileios AskoxylakisDavid P. KodackRakesh K. Jain Letter to the Editor 22 June 2017 Pages: 467 - 468
Erratum to: Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial Milagros González-RiveraMiriam LoboMiguel Martin Erratum 18 July 2017 Pages: 471 - 471
